Edwards Lifesciences | EW

Stock Price
87.89
Daily Change
-0.84 -0.94%
Monthly
-5.92%
Yearly
0.54%
Q2 Forecast
93.73
Peers Price Chg Day Year Date
ABT Abbott 106.90 -0.06 -0.06% -1.70% Apr/25
ATRC AtriCure 22.61 -0.41 -1.78% -46.49% Apr/25
BAX Baxter International 40.25 -0.73 -1.78% -12.65% Apr/25
BDX Becton, Dickinson and Co. 230.77 -3.18 -1.36% -10.73% Apr/25
BSX Boston Scientific 73.27 0.42 0.58% 43.39% Apr/25
COO Cooper Companies 89.90 -0.35 -0.38% -5.12% Apr/25
DXCM Dexcom 138.02 0.04 0.03% 10.48% Apr/25
EW Edwards Lifesciences 87.89 -0.84 -0.94% 0.54% Apr/25
GMED Globus Medical 50.37 -1.07 -2.08% -12.64% Apr/25
HOLX Hologic 75.71 -1.07 -1.39% -10.84% Apr/25
IART Integra LifeSciences 28.43 -0.95 -3.23% -47.55% Apr/25
ICUI ICU Medical 94.49 -2.23 -2.31% -47.84% Apr/25
ISRG Intuitive Surgical 371.49 -2.02 -0.54% 25.95% Apr/25
JNJ J&J 146.84 -1.73 -1.16% -9.70% Apr/25
MASI Masimo 135.35 -0.57 -0.42% -27.59% Apr/25
MDT Medtronic 79.06 -1.21 -1.50% -12.13% Apr/25
MMSI Merit Medical Systems 73.39 -0.64 -0.86% -5.51% Apr/25
PODD Insulet 164.03 -3.20 -1.91% -48.20% Apr/25
SYK Stryker 336.85 -0.45 -0.13% 12.73% Apr/25
TFX Teleflex 206.12 -5.36 -2.53% -23.19% Apr/25
TNDM Tandem Diabetes Care 35.56 0.44 1.25% -5.17% Apr/25
ZBH Zimmer Biomet Holdings 119.52 -1.64 -1.35% -14.06% Apr/25

Indexes Price Day Year Date
SPX US500 5083 -23.21 -0.46% 22.90% Apr/26
MID US400 2887 -13.99 -0.48% 18.79% Apr/25

Edwards Lifesciences traded at $87.89 this Thursday April 25th, decreasing $0.84 or 0.94 percent since the previous trading session. Looking back, over the last four weeks, Edwards Lifesciences lost 5.92 percent. Over the last 12 months, its price rose by 0.54 percent. Looking ahead, we forecast Edwards Lifesciences to be priced at 93.73 by the end of this quarter and at 88.47 in one year, according to Trading Economics global macro models projections and analysts expectations.

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.